These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25201147)

  • 61. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
    Liu W; Wang W; Wang X; Xu C; Zhang N; Di W
    Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CCR6 regulates the migration of inflammatory and regulatory T cells.
    Yamazaki T; Yang XO; Chung Y; Fukunaga A; Nurieva R; Pappu B; Martin-Orozco N; Kang HS; Ma L; Panopoulos AD; Craig S; Watowich SS; Jetten AM; Tian Q; Dong C
    J Immunol; 2008 Dec; 181(12):8391-401. PubMed ID: 19050256
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early CCR6 expression on B cells modulates germinal centre kinetics and efficient antibody responses.
    Reimer D; Lee AY; Bannan J; Fromm P; Kara EE; Comerford I; McColl S; Wiede F; Mielenz D; Körner H
    Immunol Cell Biol; 2017 Jan; 95(1):33-41. PubMed ID: 27465674
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway.
    Yu Q; Lou XM; He Y
    PLoS One; 2015; 10(3):e0120855. PubMed ID: 25768730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17.
    Meares GP; Ma X; Qin H; Benveniste EN
    Glia; 2012 May; 60(5):771-81. PubMed ID: 22319003
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.
    Lee SM; Yang H; Tartar DM; Gao B; Luo X; Ye SQ; Zaghouani H; Fang D
    Diabetologia; 2011 May; 54(5):1136-46. PubMed ID: 21340626
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interleukin-38 Suppresses Cell Migration and Proliferation and Promotes Apoptosis of Colorectal Cancer Cell Through Negatively Regulating Extracellular Signal-Regulated Kinases Signaling.
    Huang L; Zhang H; Zhao D; Hu H; Lu Z
    J Interferon Cytokine Res; 2021 Oct; 41(10):375-384. PubMed ID: 34612721
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer.
    Chang H; Wei JW; Tao YL; Ding PR; Xia YF; Gao YH; Xiao WW
    Cancer Res Treat; 2018 Oct; 50(4):1203-1213. PubMed ID: 29268566
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer.
    Ranasinghe R; Eri R
    Medicina (Kaunas); 2018 Nov; 54(5):. PubMed ID: 30453514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis.
    Paldor M; Levkovitch-Siany O; Eidelshtein D; Adar R; Enk CD; Marmary Y; Elgavish S; Nevo Y; Benyamini H; Plaschkes I; Klein S; Mali A; Rose-John S; Peled A; Galun E; Axelrod JH
    EMBO Mol Med; 2022 Aug; 14(8):e15653. PubMed ID: 35785521
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of a novel series of potent and selective CCR6 inhibitors as biological probes.
    Tawaraishi T; Sakauchi N; Hidaka K; Yoshikawa K; Okui T; Kuno H; Chisaki I; Aso K
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3067-3072. PubMed ID: 30098865
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.
    Kochi Y; Okada Y; Suzuki A; Ikari K; Terao C; Takahashi A; Yamazaki K; Hosono N; Myouzen K; Tsunoda T; Kamatani N; Furuichi T; Ikegawa S; Ohmura K; Mimori T; Matsuda F; Iwamoto T; Momohara S; Yamanaka H; Yamada R; Kubo M; Nakamura Y; Yamamoto K
    Nat Genet; 2010 Jun; 42(6):515-9. PubMed ID: 20453841
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages.
    Nandi B; Shapiro M; Samur MK; Pai C; Frank NY; Yoon C; Prabhala RH; Munshi NC; Gold JS
    Oncoimmunology; 2016 Aug; 5(8):e1189052. PubMed ID: 27622061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of atherogenesis by chemokine receptor CCR6.
    Wan W; Murphy PM
    Trends Cardiovasc Med; 2011 Jul; 21(5):140-4. PubMed ID: 22732549
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases.
    Gómez-Melero S; Caballero-Villarraso J
    Antibodies (Basel); 2023 Apr; 12(2):. PubMed ID: 37092451
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Schwann cells promote the migration and invasion of colorectal cancer cells
    Chen S; Chen M
    Front Oncol; 2022; 12():1026670. PubMed ID: 36465391
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutation-Induced Functional Alterations of CCR6.
    Julian B; Gao K; Harwood BN; Beinborn M; Kopin AS
    J Pharmacol Exp Ther; 2017 Jan; 360(1):106-116. PubMed ID: 27789680
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1.
    Li G; Cunin P; Wu D; Diogo D; Yang Y; Okada Y; Plenge RM; Nigrovic PA
    PLoS Genet; 2016 Sep; 12(9):e1006292. PubMed ID: 27626929
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.
    Franzè E; Dinallo V; Rizzo A; Di Giovangiulio M; Bevivino G; Stolfi C; Caprioli F; Colantoni A; Ortenzi A; Grazia AD; Sica G; Sileri PP; Rossi P; Monteleone G
    Oncotarget; 2018 Jan; 9(3):3432-3445. PubMed ID: 29423057
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases.
    Meyer EA; Croxford AL; Gnerre C; Kulig P; Murphy MJ; Jacob EM; Schäfer G; Richard-Bildstein S; Aissaoui H; Bouis P; Ertel EA; de Kanter R; Keller MP; Lüthi U; Caroff E
    J Med Chem; 2024 May; 67(10):8077-8098. PubMed ID: 38727100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.